Reinventing Regulatory

 

China’s National Medical Product Administration

Understanding NMPA is CRUCIAL for medical device companies planning to expand to the Chinese market. In 2015, China’s regulatory body began its reformation process which has led to its name change (from CFDA to NMPA) as well as other changes involving registration, review, communication, and many others.

 

RegDesk provides a platform where we:

      ◦ Provide the latest regulation information

      ◦ Monitor MNPA changes

      ◦ Address any concerns about the application process